Targeting At Risk Relatives Of Glaucoma Patients For Early Diagnosis And Treatment (TARRGET)
Funder
National Health and Medical Research Council
Funding Amount
$595,375.00
Summary
Glaucoma is the second leading cause of blindness in Australia but early detection and treatment can prevent blindness. We will recruit patients with advanced glaucoma from an Australia wide registry and refer their close relatives to have an eye exam and genetic testing to see if they are at risk of glaucoma. We will evaluate how a coordinator can improve the uptake of this screening program referring people to local eye care providers and in rural WA providing screening in 16 remote locations.
Evaluating A New Model Of Early Glaucoma Diagnosis
Funder
National Health and Medical Research Council
Funding Amount
$1,099,710.00
Summary
The provision of eyecare in Australia has significantly changed over the past decade. Major challenges have been created because of our ageing population with chronic ocular diseases (eg, glaucoma), expanded scope of practice including co-management options for glaucoma and dramatic expansion of technology associated with glaucoma diagnosis. Major questions have therefore arisen in relation to policy issues, service delivery and how research results are integrated with the overall aim being for ....The provision of eyecare in Australia has significantly changed over the past decade. Major challenges have been created because of our ageing population with chronic ocular diseases (eg, glaucoma), expanded scope of practice including co-management options for glaucoma and dramatic expansion of technology associated with glaucoma diagnosis. Major questions have therefore arisen in relation to policy issues, service delivery and how research results are integrated with the overall aim being for the early diagnosis of glaucoma.Read moreRead less
Optimising Computerised Decision Support To Transform Medication Safety And Reduce Prescriber Burden
Funder
National Health and Medical Research Council
Funding Amount
$325,546.00
Summary
As medication management in Australian hospitals shifts from paper to electronic formats, organisations are faced with a difficult decision: should drug-drug interaction (DDI) alerts be turned on and if so, which alerts? In this study, we propose a highly innovative approach to assess DDI alerts, which combines a robust evaluation of error rates with a human factors evaluation of alerts.